MedPath

This is a study to observe the effectiveness and safety of estradiol hemihydrate tablet usage vaginally in patients with thin endometrial for endometrial preparation in Frozen Embryo Transfer (FET) cycles

Not yet recruiting
Conditions
Pregnancy, childbirth and the puerperium,
Registration Number
CTRI/2025/04/084727
Lead Sponsor
Dr Jatin Shah
Brief Summary

This is a retrospective real world observational study to observe the effectiveness and safety of estradiol hemihydrate tablet usage vaginally in patients with thin endometrial for artificial endometrial preparation in Frozen Embryo Transfer (FET) cycles

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age 25 to 42 years (both inclusive) b.
  • Patients planned to undergo Frozen embryo transfer cycle where endometrial preparation will be done by hormone replacement therapy (HRT) c.
  • Normal pelvic ultrasonography.
Exclusion Criteria
  • Women who smoke b.
  • Women under 25 years or over 42 years of age c.
  • Women who had unexplained vaginal bleeding d.
  • Women who had Ashermans syndrome e.
  • Women with history of Malignancy, HIV and Tubercular endometritis g.
  • Any Contraindications for receiving estradiol h.
  • Hypersensitivity to estradiol or any of its excipients i.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A retrospective real world observational study to observe the effectiveness and safety of estradiolFollowing retrospective data will be collected in this study. | • Patients Age | • Duration and cause of Infertility | • Number of previous IVF treatment cycle | • Base line investigations | • Endometrial thickness - before starting and after administration of vaginal estradiol | hemihydrate; and on progesterone start day | • Pregnancy test - positive or negative 10 to 15 days after embryo
hemihydrate tablet usage vaginally in patients with thin endometrial for artificial endometrialFollowing retrospective data will be collected in this study. | • Patients Age | • Duration and cause of Infertility | • Number of previous IVF treatment cycle | • Base line investigations | • Endometrial thickness - before starting and after administration of vaginal estradiol | hemihydrate; and on progesterone start day | • Pregnancy test - positive or negative 10 to 15 days after embryo
preparation in Frozen Embryo Transfer (FET) cyclesFollowing retrospective data will be collected in this study. | • Patients Age | • Duration and cause of Infertility | • Number of previous IVF treatment cycle | • Base line investigations | • Endometrial thickness - before starting and after administration of vaginal estradiol | hemihydrate; and on progesterone start day | • Pregnancy test - positive or negative 10 to 15 days after embryo
Secondary Outcome Measures
NameTimeMethod
NANA

Trial Locations

Locations (1)

Kamala Poly Clinic & Nursing Home

🇮🇳

Mumbai, MAHARASHTRA, India

Kamala Poly Clinic & Nursing Home
🇮🇳Mumbai, MAHARASHTRA, India
Dr Jatin Shah
Principal investigator
9820080449
drjatin2000@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.